Amunix Pharmaceuticals, Inc.
Amunix is an immuno-oncology company focused on developing immune-activating biotherapeutics for patients with solid tumor cancers.
B2X
CEO
CIK Number
Legal Name
Amunix Pharmaceuticals, Inc.
Company Operating Status
Active
Country
Crunchbase URL
DUNS Number
621413512
Founder
Full Address
2 Tower Plaza Suite 1100 South San Francisco, CA 94080 United States
Latest Funding Round Date
March 2021
Latest Funding Round Amount (USD)
117,000,000
Latest Funding Type
Legal classification
LinkedIn URL
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Pitchbook URL
Place of Incorporation
Total Funding Amount (USD)
193,322,637
Official Website
Find more companies like Amunix Pharmaceuticals, Inc.
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
